Skip to main content
MRVI logo

MRVI · Maravai Lifesciences Holdings, Inc. · Analyst Estimates

Track MRVI — free
$7.66 +0.00 (+0.00%)
Market Cap
$1.97B
Shares
259.67M
Volume · Sep 30 3.61M Avg daily vol (3M) 3.24M

Analyst Estimates

Compare analyst forecasts for Maravai Lifesciences Holdings, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-01 09:01 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.15032
-0.10581
-0.08
—
-0.18077
-0.11349
-0.17739
-0.11474
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
2
2
6
6
Revenue
USD
Publication date not stated
210500000
211761810
213100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.2
-0.09824
-0.02
—
-0.10039
-0.09174
-0.10511
-0.09299
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
2
2
4
3
Revenue
USD
Publication date not stated
218300000
224647770
229500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.07725
-0.05532
-0.04
—
-0.09066
-0.0465
-0.08917
-0.0465
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
4
4
2
2
Revenue
USD
Publication date not stated
42362470
43371560
45400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06603
-0.04322
-0.03
—
-0.08378
-0.03077
-0.08156
-0.03077
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
5
5
0
0
Revenue
USD
Publication date not stated
49300000
51110630
52512000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —
Key facts CIK 1823239 CUSIP 56600D107 13F (30d) 4 filings 4 filers Visit website Investor relations